I know that this is an EVG board but I've been following EAS since December and I notice that while it has its ups and downs, it doesn't have the s/p constraints put on it like EVG does. EAS is up .37 so far today. It was around .20 in December as was EVG. So, perhaps we need more "proof" of what we have in EVG to get unshackled from this grip? It seems to me that the assays between the two companies are similar.